{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:43:30Z","timestamp":1761929010721,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pancreatology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.pan.2025.09.006","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T18:34:16Z","timestamp":1758134056000},"page":"1117-1125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of A-to-I RNA editing profiles and their clinical relevance in pancreatic neuroendocrine neoplasms"],"prefix":"10.1016","volume":"25","author":[{"given":"Yanling","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanqun","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mujie","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiyun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.pan.2025.09.006_bib1","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol"},{"issue":"2","key":"10.1016\/j.pan.2025.09.006_bib2","article-title":"The 2019 WHO classification of tumours of the digestive system","volume":"72","author":"Iris","year":"2020","journal-title":"Histopathology"},{"issue":"10","key":"10.1016\/j.pan.2025.09.006_bib3","doi-asserted-by":"crossref","first-page":"7001","DOI":"10.1245\/s10434-024-15632-y","article-title":"Subgrading of G2 pancreatic neuroendocrine tumors as 2A (Ki67 3% to < 10%) versus 2B (10% to <\/= 20%) identifies behaviorally distinct subsets in keeping with the evolving management protocols","volume":"31","author":"Eren","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.pan.2025.09.006_bib4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12022-024-09807-2","article-title":"Molecular classification of gastrointestinal and pancreatic neuroendocrine neoplasms: are we ready for that?","volume":"35","author":"Uccella","year":"2024","journal-title":"Endocr Pathol"},{"issue":"20","key":"10.1016\/j.pan.2025.09.006_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252011017","article-title":"Molecular basis of pancreatic neuroendocrine tumors","volume":"25","author":"Maluchenko","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.pan.2025.09.006_bib6","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/s41591-019-0493-4","article-title":"Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors","volume":"25","author":"Cejas","year":"2019","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.pan.2025.09.006_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.celrep.2021.109817","article-title":"Proteotranscriptomic classification and characterization of pancreatic neuroendocrine neoplasms","volume":"37","author":"Yang","year":"2021","journal-title":"Cell Rep"},{"issue":"14","key":"10.1016\/j.pan.2025.09.006_bib8","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1158\/0008-5472.CAN-17-0520","article-title":"RNA editing in pathogenesis of cancer","volume":"77","author":"Baysal","year":"2017","journal-title":"Cancer Res"},{"issue":"D1","key":"10.1016\/j.pan.2025.09.006_bib9","doi-asserted-by":"crossref","first-page":"D1396","DOI":"10.1093\/nar\/gkaa790","article-title":"RMDisease: a database of genetic variants that affect RNA modifications, with implications for epitranscriptome pathogenesis","volume":"49","author":"Chen","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.pan.2025.09.006_bib10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s43556-023-00139-x","article-title":"RNA modification: mechanisms and therapeutic targets","volume":"4","author":"Qiu","year":"2023","journal-title":"Mol Biomed"},{"issue":"1","key":"10.1016\/j.pan.2025.09.006_bib11","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12943-024-02194-6","article-title":"Advances in A-to-I RNA editing in cancer","volume":"23","author":"Zhang","year":"2024","journal-title":"Mol Cancer"},{"issue":"2","key":"10.1016\/j.pan.2025.09.006_bib12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nm.3043","article-title":"Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma","volume":"19","author":"Chen","year":"2013","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.pan.2025.09.006_bib13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.stem.2016.05.004","article-title":"ADAR1 activation drives leukemia stem cell self-renewal by impairing let-7 biogenesis","volume":"19","author":"Zipeto","year":"2016","journal-title":"Cell Stem Cell"},{"issue":"4","key":"10.1016\/j.pan.2025.09.006_bib14","doi-asserted-by":"crossref","first-page":"C837","DOI":"10.1152\/ajpcell.00024.2023","article-title":"Potential usages of A-to-I RNA editing patterns as diagnostic biomarkers","volume":"324","author":"Rodriguez Morales","year":"2023","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"10.1016\/j.pan.2025.09.006_bib15","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.celrep.2015.08.080","article-title":"Elevated RNA editing activity is a major contributor to transcriptomic diversity in tumors","volume":"13","author":"Paz-Yaacov","year":"2015","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.pan.2025.09.006_bib16","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13578-024-01216-6","article-title":"RNA editing enzymes: structure, biological functions and applications","volume":"14","author":"Zhang","year":"2024","journal-title":"Cell Biosci"},{"issue":"2","key":"10.1016\/j.pan.2025.09.006_bib17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.celrep.2015.08.080","article-title":"Elevated RNA editing activity is a major contributor to transcriptomic diversity in tumors","volume":"13","author":"Paz-Yaacov","year":"2015","journal-title":"Cell Rep"},{"issue":"4","key":"10.1016\/j.pan.2025.09.006_bib18","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ccell.2015.08.013","article-title":"The genomic landscape and clinical relevance of A-to-I RNA editing in human cancers","volume":"28","author":"Han","year":"2015","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.pan.2025.09.006_bib19","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/s41592-019-0610-9","article-title":"Genome-wide quantification of ADAR adenosine-to-inosine RNA editing activity","volume":"16","author":"Roth","year":"2019","journal-title":"Nat Methods"},{"issue":"7","key":"10.1016\/j.pan.2025.09.006_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/genes12071026","article-title":"An I for an A: dynamic regulation of adenosine deamination-mediated RNA editing","volume":"12","author":"Vesely","year":"2021","journal-title":"Genes"},{"issue":"6","key":"10.1016\/j.pan.2025.09.006_bib21","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1101\/gr.089409.108","article-title":"Large-scale mRNA sequencing determines global regulation of RNA editing during brain development","volume":"19","author":"Wahlstedt","year":"2009","journal-title":"Genome Res"},{"issue":"1","key":"10.1016\/j.pan.2025.09.006_bib22","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1186\/s12885-022-09773-0","article-title":"A nomogram based on A-to-I RNA editing predicting overall survival of patients with lung squamous carcinoma","volume":"22","author":"Liu","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.pan.2025.09.006_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.861439","article-title":"Development and validation of a four adenosine-to-inosine RNA editing site-relevant prognostic signature for assessing survival in breast cancer patients","volume":"12","author":"Wan","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.pan.2025.09.006_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.932876","article-title":"Crosstalk of RNA adenosine modification-related subtypes, establishment of a prognostic model, and immune infiltration characteristics in ovarian cancer","volume":"13","author":"Ni","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.pan.2025.09.006_bib25","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1186\/s12967-018-1740-z","article-title":"Enhanced AZIN1 RNA editing and overexpression of its regulatory enzyme ADAR1 are important prognostic biomarkers in gastric cancer","volume":"16","author":"Okugawa","year":"2018","journal-title":"J Transl Med"},{"issue":"21","key":"10.1016\/j.pan.2025.09.006_bib26","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1182\/blood.2024027379","article-title":"Advances in RNA editing in hematopoiesis and associated malignancies","volume":"145","author":"Pu","year":"2025","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.pan.2025.09.006_bib27","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s11658-025-00718-6","article-title":"A novel mechanism for A-to-I RNA-edited CYP1A1 in promoting cancer progression in NSCLC","volume":"30","author":"Wang","year":"2025","journal-title":"Cell Mol Biol Lett"},{"issue":"1","key":"10.1016\/j.pan.2025.09.006_bib28","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s12672-025-02449-8","article-title":"A-to-I RNA edited POLA2 attains carcinogenesis in prostatic cancer by impeding immune infiltration and upregulating BTBD7","volume":"16","author":"Lin","year":"2025","journal-title":"Discov Oncol"},{"issue":"1","key":"10.1016\/j.pan.2025.09.006_bib29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11427-020-1928-0","article-title":"Identification of A-to-I RNA editing profiles and their clinical relevance in lung adenocarcinoma","volume":"65","author":"Wang","year":"2022","journal-title":"Sci China Life Sci"}],"container-title":["Pancreatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390325006143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390325006143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:39:09Z","timestamp":1761928749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1424390325006143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1424390325006143"],"URL":"https:\/\/doi.org\/10.1016\/j.pan.2025.09.006","relation":{},"ISSN":["1424-3903"],"issn-type":[{"type":"print","value":"1424-3903"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of A-to-I RNA editing profiles and their clinical relevance in pancreatic neuroendocrine neoplasms","name":"articletitle","label":"Article Title"},{"value":"Pancreatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pan.2025.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 IAP and EPC. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}